BioHarvest Sciences Inc. (BHST)

BioHarvest says its platform can produce target sweetener in Tate & Lyle program

Tate & Lyle and Bioharvest Reach Key Milestone in Next-Generation Sweetener Development Programme

BioHarvest Sciences launches buyback of up to 5% of shares

BioHarvest Sciences Announces Share Repurchase Program

BioHarvest Advances Botanical Synthesis Leadership as VINIA Daily Chews Unlock More Value from Its First Consumer Product

BioHarvest Sciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Fiinu shares jump over 6% as Conister Bank platform enters production

BioHarvest Sciences plans Tel Aviv Stock Exchange dual listing

BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)

BioHarvest Sciences Inc. (BHST) Q2 2026 Earnings Call Transcript

BioHarvest Sciences Q2 Earnings Call Highlights

BioHarvest posts higher Q2 revenue, secures manufacturing deal for premium fragrance compound

BioHarvest Sciences Inc. (BHST) Reports Q2 Loss, Lags Revenue Estimates

BioHarvest Reports Second Quarter 2026 Financial Results and Provides Business Update

BioHarvest Secures 20-Ton Manufacturing and Supply Agreement for Rare Botanical Luxury Fragrance

Head-To-Head Analysis: BioHarvest Sciences (NASDAQ:BHST) versus Nu Skin Enterprises (NYSE:NUS)

BioHarvest Sciences to Present at the Canaccord Genuity 46th Annual Growth Conference

BioHarvest Sciences to Report Second Quarter 2026 Financial Results on August 11, 2026

BioHarvest lands $1.4M grant for AI-driven plant science

BioHarvest Awarded $1.4M Grant from the Israel Innovation Authority to Pioneer AI-Driven Plant-Cell Synthesis